Pharmaceutical company Johnson & Johnson (J&J) was ordered to pay $5.7 million to the plaintiff in its first trial related to injuries from TVT Abbrevo, a transvaginal mesh device. A California jury found the company liable for problems connected to the design of TVT Abbrevo. Additionally, the jury found that J&J failed to warn consumers of its risks.
According to Reuters, this verdict is the fourth win for plaintiffs suing J&J and its Ethicon Inc. unit for transvaginal mesh products. In total, more than 36,000 lawsuits have been filed against the company and its transvaginal mesh devices.
Abbrevo is one of Ethicon’s newer transvaginal mesh products and was approved by the U.S. Food and Drug Administration (FDA) in 2010. The device was approved to treat stress urinary incontinence.
Along with many other transvaginal mesh devices, however, Abbrevo has caused serious injuries among women, including erosion of the device through the vaginal epithelium and other parts of the body. This can cause intense pain and lasting negative effects.
Other transvaginal mesh complications include:
- Erosion through vaginal epithelium (the tissue inside the vagina)
- Urinary problems
- Recurrence of prolapse and/or incontinence
- Bowel, bladder and blood vessel perforation during insertion
- Vaginal scarring
- Mesh erosion causing discomfort, pain and/or dyspareunia (painful intercourse)
A total of seven companies are facing transvaginal mesh lawsuits filed by women and their loved ones who have been seriously injured. J&J’s Ethicon, Boston Scientific Corp and C.R. Bard are three of the seven companies.
The lawyers at Simmons Hanly Conroy are currently investigating claims for women who have suffered complications from transvaginal mesh. If you or a loved one had pelvic organ prolapse and have undergone a transvaginal surgical mesh procedure, please contact one of our transvaginal mesh lawyers. We are here to help and can answer any questions you might have.